ALKS
Price
$31.42
Change
+$0.21 (+0.67%)
Updated
May 16 closing price
Capitalization
4.55B
67 days until earnings call
CLCFF
Price
$0.04
Change
-$0.00 (-0.00%)
Updated
May 15 closing price
Capitalization
3.96M
Ad is loading...

ALKS vs CLCFF

Header iconALKS vs CLCFF Comparison
Open Charts ALKS vs CLCFFBanner chart's image
Alkermes
Price$31.42
Change+$0.21 (+0.67%)
Volume$992.69K
Capitalization4.55B
Christina Lake Cannabis
Price$0.04
Change-$0.00 (-0.00%)
Volume$6.58K
Capitalization3.96M
ALKS vs CLCFF Comparison Chart
Loading...
ALKS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALKS vs. CLCFF commentary
May 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALKS is a Hold and CLCFF is a Hold.

Ad is loading...
COMPARISON
Comparison
May 17, 2025
Stock price -- (ALKS: $31.21 vs. CLCFF: $0.04)
Brand notoriety: ALKS and CLCFF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ALKS: 40% vs. CLCFF: 12%
Market capitalization -- ALKS: $4.55B vs. CLCFF: $3.96M
ALKS [@Pharmaceuticals: Other] is valued at $4.55B. CLCFF’s [@Pharmaceuticals: Other] market capitalization is $3.96M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALKS’s FA Score shows that 2 FA rating(s) are green whileCLCFF’s FA Score has 1 green FA rating(s).

  • ALKS’s FA Score: 2 green, 3 red.
  • CLCFF’s FA Score: 1 green, 4 red.
According to our system of comparison, ALKS is a better buy in the long-term than CLCFF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALKS’s TA Score shows that 4 TA indicator(s) are bullish.

  • ALKS’s TA Score: 4 bullish, 5 bearish.

Price Growth

ALKS (@Pharmaceuticals: Other) experienced а +2.73% price change this week, while CLCFF (@Pharmaceuticals: Other) price change was +18.75% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.72%. For the same industry, the average monthly price growth was +12.60%, and the average quarterly price growth was +27.89%.

Reported Earning Dates

ALKS is expected to report earnings on Jul 23, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.72% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALKS($4.55B) has a higher market cap than CLCFF($3.96M). CLCFF YTD gains are higher at: 153.333 vs. ALKS (8.519). ALKS has higher annual earnings (EBITDA): 519M vs. CLCFF (-1.34M). ALKS has more cash in the bank: 773M vs. CLCFF (1.53M). CLCFF has less debt than ALKS: CLCFF (6.45M) vs ALKS (372M). ALKS has higher revenues than CLCFF: ALKS (1.66B) vs CLCFF (10.3M).
ALKSCLCFFALKS / CLCFF
Capitalization4.55B3.96M115,011%
EBITDA519M-1.34M-38,729%
Gain YTD8.519153.3336%
P/E Ratio8.90N/A-
Revenue1.66B10.3M16,146%
Total Cash773M1.53M50,556%
Total Debt372M6.45M5,767%
FUNDAMENTALS RATINGS
ALKS: Fundamental Ratings
ALKS
OUTLOOK RATING
1..100
26
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
25
SMR RATING
1..100
36
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
7
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALKS
RSI
ODDS (%)
Bearish Trend 2 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
60%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 15 days ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
63%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
55%
Aroon
ODDS (%)
Bearish Trend 2 days ago
57%
View a ticker or compare two or three
Ad is loading...
ALKS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY590.462.87
+0.49%
SPDR® S&P 500® ETF
BTC.X103744.640000205.226560
+0.20%
Bitcoin cryptocurrency
GME28.63-0.10
-0.35%
GameStop Corp
AAPL211.45-0.88
-0.41%
Apple
TSLA342.82-4.86
-1.40%
Tesla

ALKS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALKS has been loosely correlated with ESPR. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if ALKS jumps, then ESPR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALKS
1D Price
Change %
ALKS100%
+1.93%
ESPR - ALKS
33%
Loosely correlated
+6.47%
PAHC - ALKS
33%
Poorly correlated
+2.01%
DVAX - ALKS
32%
Poorly correlated
+1.17%
VTRS - ALKS
31%
Poorly correlated
+4.39%
PRGO - ALKS
31%
Poorly correlated
+1.08%
More

CLCFF and

Correlation & Price change

A.I.dvisor tells us that CLCFF and ALKS have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLCFF and ALKS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLCFF
1D Price
Change %
CLCFF100%
+5.26%
ALKS - CLCFF
23%
Poorly correlated
+1.93%
RGC - CLCFF
21%
Poorly correlated
+17.20%
LVZPF - CLCFF
6%
Poorly correlated
N/A
HYEX - CLCFF
6%
Poorly correlated
-13.33%
GEDSF - CLCFF
6%
Poorly correlated
N/A
More